AU2001291934A1 - Means for regulating immune defences - Google Patents

Means for regulating immune defences

Info

Publication number
AU2001291934A1
AU2001291934A1 AU2001291934A AU9193401A AU2001291934A1 AU 2001291934 A1 AU2001291934 A1 AU 2001291934A1 AU 2001291934 A AU2001291934 A AU 2001291934A AU 9193401 A AU9193401 A AU 9193401A AU 2001291934 A1 AU2001291934 A1 AU 2001291934A1
Authority
AU
Australia
Prior art keywords
regulating immune
immune defences
defences
regulating
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291934A
Other languages
English (en)
Inventor
Amar Achour
Jean-Marie Andrieu
Wei Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INSTITUT NECKER
Original Assignee
INST NECKER
INSTITUT NECKER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST NECKER, INSTITUT NECKER filed Critical INST NECKER
Publication of AU2001291934A1 publication Critical patent/AU2001291934A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001291934A 2000-09-12 2001-09-11 Means for regulating immune defences Abandoned AU2001291934A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0011567 2000-09-12
FR0011567A FR2813792B1 (fr) 2000-09-12 2000-09-12 Moyens pour la regulation des defenses immunitaires
PCT/FR2001/002810 WO2002022130A2 (fr) 2000-09-12 2001-09-11 Moyens pour la regulation des defenses immunitaires

Publications (1)

Publication Number Publication Date
AU2001291934A1 true AU2001291934A1 (en) 2002-03-26

Family

ID=8854177

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291934A Abandoned AU2001291934A1 (en) 2000-09-12 2001-09-11 Means for regulating immune defences

Country Status (3)

Country Link
AU (1) AU2001291934A1 (fr)
FR (1) FR2813792B1 (fr)
WO (1) WO2002022130A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005046694A1 (fr) 2003-11-13 2005-05-26 Københavns Universitet Thioridazine et ses derives, utilises pour inverser la resistance aux medicaments antimicrobiens
WO2008080398A1 (fr) * 2007-01-05 2008-07-10 Bkg Pharma Aps Agents anti-infectieux tels que des dérivés de phénothiazine et de thioxanthène pour traiter les maladies infectieuses
EP2758403B1 (fr) 2011-09-21 2016-04-27 Inception Orion, Inc. Composés tricycliques utiles comme agents neurogènes et neuroprotecteurs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM910192A1 (it) * 1990-04-03 1991-10-04 American Cyanamid Co Metodo per invertire la resistenza a bisantrene mediata da p-glicoproteine.
DE19533574A1 (de) * 1995-09-11 1997-03-13 Oskoui Kaveh Bastani Stoff und Mittel mit Prolaktinämiewirkung

Also Published As

Publication number Publication date
WO2002022130A2 (fr) 2002-03-21
WO2002022130A3 (fr) 2002-06-13
FR2813792A1 (fr) 2002-03-15
FR2813792B1 (fr) 2003-03-14

Similar Documents

Publication Publication Date Title
AU5784100A (en) Method for enhancing an immune response
AU2001293189A1 (en) Compositions and methods for regulating apoptosis
GB2390589B (en) System for controlling streamers
AU2001290102A1 (en) Control apparatus
EP1193401A3 (fr) Soupape de commande à pressions multiples avec clapet à bille
AU2770601A (en) Compositions for enhancing the immune response
AU2001238125A1 (en) Hydristor control means
AU2001237530A1 (en) Method
AU2001266176A1 (en) Methods
AU2001291934A1 (en) Means for regulating immune defences
AU2001269283A1 (en) Distributed control method
AU2001241636A1 (en) Halotherapy method
AU2001245513A1 (en) Method for immune switching
AU5169400A (en) Personalized metabrowser
AU2001287621A1 (en) Controlling device
AU2001250536A1 (en) Methods
EP1213188A3 (fr) Dispositif de commande
AU6611301A (en) Weight regulating method by restoring gustatory function
AU2002317400A1 (en) Electro-optic controlsystem
AU2001281048A1 (en) Floral induction gene
AU2945599A (en) Immune response
AU2001295689A1 (en) Compositions and methods for regulating the nervous system
AU2002352392A1 (en) Methods and means for modulating the immune response
AU2001256535A1 (en) Control circuitry
AU2001234322A1 (en) Control system